Acne Claims For Cosmetics Leave Blemish On UK Advertising Regs
Executive SummaryAdvertising Standards Authority issued decisions Oct. 17 on complaints against three cosmetics brands and an online beauty retailer for statements the independent regulator reads as acne-treatment claims, or the “spots” equivalent, calling them medicinal claims for unlicensed products.
You may also be interested in...
FDA’s warning letter to Skin 2 Sprit prompts a quick fix of website claims for the company’s skin care products. FDA advises Moon Valley Natural Products to correct claims that quality its skin care products as misbranded drugs.
Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.
The European Commission issued requests on 4 February for updated opinions from the Scientific Committee on Consumer Safety on octocrylene, homosalate and benzophenone-3, in light of concerns that led to their listing in 2019 as “higher priority” substances used in cosmetics with endocrine-disrupting potential.